24/7 Wall St. set a $98.56 12-month target for OKLO stock on July 9, 2026, implying 100.03% upside from its $49.27 price. The call leaves shareholders with a simple math problem: the stock could double, but only if Oklo turns regulatory progress and customer commitments into revenue.
$49.27 was the share price on July 9, 2026, when the new target landed, and the recommendation was buy with a 50% confidence level. For holders who bought near the 52-week low of $44.88, the latest call keeps the valuation debate centered on how much upside the market is still willing to assign to a pre-revenue company.
June Hold target at $54.06
$54.06 was Guggenheim’s June target, with a Hold rating, and it sat far below the new $98.56 call. That gap matters because it shows how quickly the valuation range can widen on a stock that already carries an $8.3 billion market cap while still lacking operating revenue.
$73.62 million was Oklo’s FY2024 net loss, and roughly $12.5 million of that came from stock-based compensation. R&D spend nearly tripled year over year, which tells you the company is still paying up front for technology, staffing, and development rather than collecting sales.
DOE approval on July 1
July 1, 2026 brought DOE approval of the Documented Safety Analysis for the Groves Isotope Test Reactor, with first criticality targeted for July 2026. That is the kind of regulatory step that can move a project from paperwork into physical testing, and it sits alongside Oklo’s 14 GW customer pipeline, the binding 1.2 gigawatt Meta agreement in Ohio, and the Centrus Energy HALEU LOI.
Late 2027 is the target for commercial power at Aurora at Idaho National Laboratory, so the company is still several steps from meaningful operating cash flow. Oklo also completed the Creative Engineers acquisition, adding one more execution layer to a buildout that depends on approvals, supply, and delivery.
Oklo Stock versus pre-revenue risk
$1.65 billion of short interest, or 19.29% of float, shows how much capital is still betting against the story even after the latest optimism. Oklo’s stock also peaked at $193.84 in October and then reset sharply this year, while shares were down 31.34% year to date and 12.77% in the past month.
$67 million in institutional bullish options activity drew attention the same day as the target, but the harder question is whether the company can convert the pipeline into sales before the valuation math breaks. If Oklo can keep regulatory momentum and customer execution intact, the $98.56 target leaves room for another re-rating; if not, the gap between a buy call and a Hold view will keep narrowing around the same unresolved issue: when revenue arrives.
